Renaissance Technologies’s Twist Bioscience TWST Stock Holding History

Renaissance Technologies’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,800	Closed	-$508K	–	3939
2025 Q2	$508K	Sell	13,800 -180,108	-93%	-$6.22M	﹤0.01%	2823
2025 Q1	$7.61M	Sell	193,908 -204,800	-51%	-$9.22M	0.01%	1163
2024 Q4	$18.5M	Buy	398,708 +184,398	+86%	+$8.33M	0.03%	706
2024 Q3	$9.68M	Buy	+214,310	New	+$10.2M	0.01%	1063
2024 Q2	–	Sell	-35,610	Closed	-$1.22M	–	3968
2024 Q1	$1.22M	Buy	+35,610	New	+$1.29M	﹤0.01%	2358
2020 Q1	–	Sell	-9,800	Closed	-$206K	–	3802
2019 Q4	$206K	Buy	+9,800	New	+$229K	﹤0.01%	3192
2019 Q3	–	Sell	-32,000	Closed	-$928K	–	3708
2019 Q2	$928K	Buy	+32,000	New	+$846K	﹤0.01%	2711

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Renaissance Technologies's TWST Position: Q3 2025 in Review

Renaissance Technologies sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 13,800 shares — an estimated $508K sold.

Renaissance Technologies first reported a position in TWST in Q2 2019 and held it in 7 quarters. The position peaked at $18.5M in Q4 2024. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

Renaissance Technologies reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
Renaissance Technologies sold 13,800 Twist Bioscience shares in Q3 2025, an estimated $508K.
Renaissance Technologies first reported a position in Twist Bioscience in Q2 2019 and held it in 7 quarters.
Renaissance Technologies's Twist Bioscience position peaked at $18.5M in Q4 2024.
238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.